menu
    • menu

    Company profile for Alcresta Therapeutics

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Alcresta Therapeutics is dedicated to developing and commercializing novel, enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases.The company uses its proprietary technology platform to support a broad pipeline of products, with an initial focus on pancreatic insufficiency or fat malabsorption, which results in malabsorption common in cystic fibrosis, dige...
    Alcresta Therapeutics is dedicated to developing and commercializing novel, enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases.The company uses its proprietary technology platform to support a broad pipeline of products, with an initial focus on pancreatic insufficiency or fat malabsorption, which results in malabsorption common in cystic fibrosis, digestive cancers, preterm birth, and other serious disease.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Alcresta TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Alcresta Therapeutics, Inc. One Newton Executive Park Suite 100 Newton, MA 024...
    Telephone
    Telephone
    + 617-431-3600
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.alcresta.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/alcresta-therapeutics-inc./
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Linden Capital Partners Acquires Alcresta Therapeutics, Inc.
    Linden Capital Partners Acquires Alcresta Therapeutics, Inc.

    12 Mar 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/linden-capital-partners-acquires-alcresta-therapeutics-inc-302086718.html

    PR NEWSWIRE
    12 Mar 2024
    Share Share
    Alcresta Announces Move to New Corporate Headquarters in Waltham, MA
    Alcresta Announces Move to New Corporate Headquarters in Waltham, MA

    05 Dec 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/alcresta-therapeutics-announces-move-to-new-corporate-headquarters-in-waltham-ma-301694151.html

    PRNEWSWIRE
    05 Dec 2022
    Share Share
    Alcresta Therapeutics Announces Appointment of Chris Parrish as COO
    Alcresta Therapeutics Announces Appointment of Chris Parrish as COO

    29 Nov 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/alcresta-therapeutics-announces-appointment-of-chris-parrish-as-chief-operations-officer-301430689.html

    PRNEWSWIRE
    29 Nov 2021
    Share Share
    Data from the ASSURE Study of Long-Term Use of RELiZORB® (iMMOBILIZED LIPASE) CARTRIDGE Published in Journal of Pediatric Gastroenterology and Nutrition
    Data from the ASSURE Study of Long-Term Use of RELiZORB® (iMMOBILIZED LIPASE) CARTRIDGE Published in Journal of Pediatric Gastroenterology and Nutrition

    02 Aug 2018

    // PRESS RELEASE

    http://www.alcresta.com/news/data-assure-study-long-term-use-relizorb%C2%AE-immobilized-lipase-cartridge-published-journal

    PRESS RELEASE
    02 Aug 2018
    Share Share
    Alcresta Announces RELiZORB® iMMOBILIZED LIPASE CARTRIDGE Issued (Q9994) by CMS
    Alcresta Announces RELiZORB® iMMOBILIZED LIPASE CARTRIDGE Issued (Q9994) by CMS

    19 Jun 2018

    // BIOSPACE

    https://www.biospace.com/article/releases/alcresta-therapeutics-announces-relizorb-immobilized-lipase-cartridge-has-been-issued-a-unique-q-code-q9994-by-cms/

    BIOSPACE
    19 Jun 2018
    Share Share
    Alcresta Presented Results at the North American Cystic F Conference-RELiZORB®
    Alcresta Presented Results at the North American Cystic F Conference-RELiZORB®

    06 Nov 2017

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20171106005237/en/Alcresta-Therapeutics-Presented-Results-North-American-Cystic

    BUSINESSWIRE
    06 Nov 2017
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search